Literature DB >> 29894743

Effect of high glucose on cytokine production by human peripheral blood immune cells and type I interferon signaling in monocytes: Implications for the role of hyperglycemia in the diabetes inflammatory process and host defense against infection.

Ronghua Hu1, Chang-Qing Xia2, Edward Butfiloski3, Michael Clare-Salzler3.   

Abstract

The major metabolic feature of diabetes is hyperglycemia which has been linked to the diabetes inflammatory processes, and diabetes-related vulnerability to infection. In the present study, we assessed how glucose affected PBMCs in type I interferon (IFN) production and subsequent signaling. We found that the moderately elevated glucose promoted, and high glucose suppressed type I IFN production, respectively. Pre-exposure to high glucose rendered monocytes more sensitive to IFN-α stimulation with heightened signaling, whereas, instantaneous addition of high glucose did not exhibit such effect. Consistent with this finding, the mRNA levels of IFN-α-induced IRF-7 in PBMCs were positively correlated with HbA1c levels of diabetes patients. Additionally, we found that high glucose promoted the production of other proinflammatory cytokines/chemokines. This study suggests that hyperglycemia may affect the inflammatory process in diabetes via promoting proinflammatory cytokines, as well as the host defense against microbial infections through impeding type I IFN production and signaling.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cytokine; Diabetes; Glucose; Hyperglycemia; Inflammation; Interferon

Mesh:

Substances:

Year:  2018        PMID: 29894743      PMCID: PMC6119493          DOI: 10.1016/j.clim.2018.06.003

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  55 in total

1.  Soluble RAGE and the RAGE ligands HMGB1 and S100A12 in critical illness: impact of glycemic control with insulin and relation with clinical outcome.

Authors:  Catherine Ingels; Inge Derese; Pieter J Wouters; Greet Van den Berghe; Ilse Vanhorebeek
Journal:  Shock       Date:  2015-02       Impact factor: 3.454

Review 2.  Monocyte chemoattractant protein-1--a major contributor to the inflammatory process associated with diabetes.

Authors:  Elena Dragomir; Maya Simionescu
Journal:  Arch Physiol Biochem       Date:  2006 Oct-Dec       Impact factor: 4.076

Review 3.  Patients at high risk of tuberculosis recurrence.

Authors:  Mehdi Mirsaeidi; Ruxana T Sadikot
Journal:  Int J Mycobacteriol       Date:  2018 Jan-Mar

Review 4.  Lipids and immunoinflammatory pathways of beta cell destruction.

Authors:  Yumi Imai; Anca D Dobrian; Margaret A Morris; David A Taylor-Fishwick; Jerry L Nadler
Journal:  Diabetologia       Date:  2016-02-11       Impact factor: 10.122

Review 5.  HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation.

Authors:  José Augusto Nogueira-Machado; Caroline Maria de Oliveira Volpe; Clara Araujo Veloso; Miriam Martins Chaves
Journal:  Expert Opin Ther Targets       Date:  2011-05-17       Impact factor: 6.902

Review 6.  Infections in diabetes mellitus and hyperglycemia.

Authors:  Smita Gupta; Janak Koirala; Romesh Khardori; Nancy Khardori
Journal:  Infect Dis Clin North Am       Date:  2007-09       Impact factor: 5.982

7.  Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis.

Authors:  Prabhakara R Nagareddy; Andrew J Murphy; Roslynn A Stirzaker; Yunying Hu; Shiquing Yu; Rachel G Miller; Bhama Ramkhelawon; Emilie Distel; Marit Westerterp; Li-Shin Huang; Ann Marie Schmidt; Trevor J Orchard; Edward A Fisher; Alan R Tall; Ira J Goldberg
Journal:  Cell Metab       Date:  2013-05-07       Impact factor: 27.287

Review 8.  Micro-environment and intracellular metabolism modulation of adipose tissue macrophage polarization in relation to chronic inflammatory diseases.

Authors:  Xiao Zhu; Yixuan Tu; Hainan Chen; Ampadu O Jackson; Vaibhav Patel; Kai Yin
Journal:  Diabetes Metab Res Rev       Date:  2018-03-30       Impact factor: 4.876

9.  A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes.

Authors:  Ricardo C Ferreira; Hui Guo; Richard M R Coulson; Deborah J Smyth; Marcin L Pekalski; Oliver S Burren; Antony J Cutler; James D Doecke; Shaun Flint; Eoin F McKinney; Paul A Lyons; Kenneth G C Smith; Peter Achenbach; Andreas Beyerlein; David B Dunger; David G Clayton; Linda S Wicker; John A Todd; Ezio Bonifacio; Chris Wallace; Anette-G Ziegler
Journal:  Diabetes       Date:  2014-02-21       Impact factor: 9.461

10.  Analysis of patients with diabetes and complicated intra-abdominal infection or complicated urinary tract infection in phase 3 trials of ceftolozane/tazobactam.

Authors:  Myra W Popejoy; Jianmin Long; Jennifer A Huntington
Journal:  BMC Infect Dis       Date:  2017-05-02       Impact factor: 3.090

View more
  22 in total

1.  Hyperglycemia minimally alters primary self-renewing human colonic epithelial cells while TNFα-promotes severe intestinal epithelial dysfunction.

Authors:  Johanna S Dutton; Samuel S Hinman; Raehyun Kim; Peter J Attayek; Mallory Maurer; Christopher S Sims; Nancy L Allbritton
Journal:  Integr Biol (Camb)       Date:  2021-06-15       Impact factor: 2.192

Review 2.  Herbal medications and natural products for patients with covid-19 and diabetes mellitus: Potentials and challenges.

Authors:  Abdurrahman Pharmacy Yusuf; Jian-Ye Zhang; Jing-Quan Li; Aliyu Muhammad; Murtala Bello Abubakar
Journal:  Phytomed Plus       Date:  2022-04-18

Review 3.  Exposome and Immunity Training: How Pathogen Exposure Order Influences Innate Immune Cell Lineage Commitment and Function.

Authors:  Kevin Adams; K Scott Weber; Steven M Johnson
Journal:  Int J Mol Sci       Date:  2020-11-11       Impact factor: 5.923

Review 4.  COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus.

Authors:  Hayder M Al-Kuraishy; Ali I Al-Gareeb; M Alblihed; Susana G Guerreiro; Natália Cruz-Martins; Gaber El-Saber Batiha
Journal:  Front Cardiovasc Med       Date:  2021-05-20

Review 5.  The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System.

Authors:  Gholamreza Daryabor; Mohamad Reza Atashzar; Dieter Kabelitz; Seppo Meri; Kurosh Kalantar
Journal:  Front Immunol       Date:  2020-07-22       Impact factor: 7.561

Review 6.  Socioeconomic Deprivation, Adverse Childhood Experiences and Medical Disorders in Adulthood: Mechanisms and Associations.

Authors:  Gerwyn Morris; Michael Berk; Michael Maes; André F Carvalho; Basant K Puri
Journal:  Mol Neurobiol       Date:  2019-01-26       Impact factor: 5.590

7.  Evidence for a More Disrupted Immune-Endocrine Relation and Cortisol Immunologic Influences in the Context of Tuberculosis and Type 2 Diabetes Comorbidity.

Authors:  Rocío D V Fernández; Ariana Díaz; Bettina Bongiovanni; Georgina Gallucci; Diego Bértola; Walter Gardeñez; Susana Lioi; Yésica Bertolin; Romina Galliano; María L Bay; Oscar Bottasso; Luciano D'Attilio
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-20       Impact factor: 5.555

Review 8.  From Influenza Virus to Novel Corona Virus (SARS-CoV-2)-The Contribution of Obesity.

Authors:  Indranil Bhattacharya; Chafik Ghayor; Ana Pérez Dominguez; Franz E Weber
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-06       Impact factor: 5.555

9.  Elevated glycohemoglobin is linked to critical illness in CoVID-19: a retrospective analysis.

Authors:  Samuel Windham; Melissa P Wilson; Connor Fling; David Sheneman; Taylor Wand; Lyndsey Babcock; Samantha MaWhinney; Kristine M Erlandson
Journal:  Ther Adv Infect Dis       Date:  2021-06-25

Review 10.  Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes.

Authors:  Aman Rajpal; Leili Rahimi; Faramarz Ismail-Beigi
Journal:  J Diabetes       Date:  2020-09-02       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.